Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections
Clinical trial NCT00711802 · COMPLETED
Trial details
- NCT number
- NCT00711802
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-23
- Primary completion
- 2013-10-11
- Enrollment
- 396
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.